Zimbabwe has turned down a substantial American healthcare agreement worth $367m (272 million pounds) over five years over the United States' request for sensitive biological samples.
This move was revealed following a government memo from December was leaked, revealing that President Emmerson Mnangagwa believed the deal was "skewed".
An official spokesman has since stated that the US was requesting biological samples for research and commercial gain but was unwilling to guarantee the resulting advantages from future vaccines.
"We are forced to start the difficult and regrettable task of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had furnished more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for further talks to find a agreement agreeable to both sides so the country's vital HIV programme can continue.
Wider Context
This rejection comes after a similar situation in Kenya, where a court blocked a similar health funding agreement after legal challenges were raised about the safety of citizens' health data.
Since returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking direct bilateral agreements to enhance transparency and accountability.
According to statements, 16 African countries have so far agreed to these new agreements, constituting more than $18.3bn in new funding.
Details of the Rejected Deal
This assistance for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment through US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, without any equivalent promise of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," he stated.
"Put simply, our nation would supply the basic resources for scientific discovery with no certainty that the final treatments would be available to our population should a new disease outbreak emerge."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the global health body and its pursuit of one-on-one health agreements were upending structures already set up through the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential global health emergencies.
"This mechanism is designed to ensure that when a nation provides its information, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to develop them."
The government's concerns over the US deal "are not meant as opposition to America," Mangwana stressed.
"We are open to further discussions with our US partners on how subsequent collaboration might be structured in a manner that respects the sovereignty and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but urged that talks must proceed given that a large portion of the nation's Aids initiatives relied on international support.
"In cases where technical issues arise, including those involving information security or agreement terms, these can frequently be resolved via detailed discussion and mutually agreed protections," it added.
The situation underscores the continuing debate between receiving crucial foreign assistance and protecting local interests in an increasingly interconnected world.